Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide Effect on Embryo Quality in Overweight and Obese IVF Patients
2025-522525-34-00Phase 4Authorised
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of semaglutide in infertility, obesity and Overweight (2 arms), sponsored by Fundació Santiago Dexeus Font. Primary endpoint: Number of good quality blastocysts. Planned start Oct 2025; status: authorised.
02
Drugs
03
Conditions
infertilityobesityOverweight
Beyond the preview
Go deeper on 2025-522525-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522525-34-00.